Zhenxiang Capital
Overview
Zhenxiang Capital is a Chinese fund management company that focuses on equity investments, private placements, and mergers & acquisitions in high-tech industries, including healthcare, TMT, new energy, and new materials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai Desano Pharmaceutical Group Co., Ltd. | Feb 2023 | Private Equity | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zhenxiang Capital based?
Zhenxiang Capital is headquartered in Beijing, China.
When was Zhenxiang Capital founded?
Zhenxiang Capital was founded in 2017.
How many portfolio companies does Zhenxiang Capital have?
Zhenxiang Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Zhenxiang Capital's portfolio?
Portfolio companies visible on Caplight include Shanghai Desano Pharmaceutical Group Co., Ltd..
What was Zhenxiang Capital's most recent investment shown here?
Zhenxiang Capital's most recent investment in this portfolio sample was in Shanghai Desano Pharmaceutical Group Co., Ltd. in 2023.
What sectors does Zhenxiang Capital focus on?
Zhenxiang Capital focuses on Healthcare & Life Sciences.
What company stages does Zhenxiang Capital focus on?
Stage focus information for Zhenxiang Capital is not publicly available.
What is Zhenxiang Capital's AUM?
Zhenxiang Capital's assets under management are estimated between $1.7B and $1.9B.